481TiP Pembrolizumab (MK-3475) versus platinum-based chemotherapy for PD-L1+ non-small cell lung cancer (NSCLC): Randomized, open-label, phase 3 KEYNOTE-042 study
| Autor: | Reshma A. Rangwala, Tony Mok, G. de Lima Lopes, Jin Zhang, Sara Sadowski, Y-L. Wu |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
Chemotherapy medicine.medical_specialty biology business.industry medicine.medical_treatment chemistry.chemical_element non-small cell lung cancer (NSCLC) Hematology Pembrolizumab medicine.disease Chemotherapy regimen chemistry PD-L1 Internal medicine medicine biology.protein Open label business Platinum |
| Zdroj: | Annals of Oncology. 26:ix125 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdv532.65 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|